NCT02689336 2019-09-09
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
Phase 2 Withdrawn
Clinical Trials
8 trialsNCT03275558 2018-07-19
Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
Center Trials & Treatment
Phase 1 Withdrawn
NCT01740570 2018-01-19
Phase I/II Cabazitaxel for Recurrent Malignant Glioma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT02194452 2017-04-28
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
University of Iowa
Phase NA Withdrawn
NCT00734864 2012-11-21
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
Duke University
Phase 1 Withdrawn
NCT00005083 2012-10-04
Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT00005790 2012-06-11
Perfusion Magnetic Resonance Imaging in Measuring the Growth of Blood Vessels in Newly Diagnosed Brain Tumors
Northwestern University
Phase NA Withdrawn
NCT00003564 2012-02-22
Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas
M.D. Anderson Cancer Center
Phase 3 Withdrawn